Sangamo Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0R1D.L | SRPT | TNYA | LXEO | SANA | CRSP | |
|---|---|---|---|---|---|---|
| Market cap | — | 1.96B | 88.84M | 246.26M | 703.50M | 4.88B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | 7.6 | -1.0 | -2.2 | -4.2 | -14.2 |
| Price/book | -2.3 | 1.3 | 1.3 | 1.0 | 4.6 | 2.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −61.37% | −14.69% | −75.88% | −67.28% | −57.09% | −25.02% |
| Today | +4.55% | −3.18% | −3.37% | −0.66% | −0.42% | +1.24% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All 0R1D.L news ›Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program
Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026 Previously announced asset sale transactions with PTC and Lilly have closed, generating $163.55 million in gross…
Sangamo Therapeutics: Nasdaq gives delisting notice
Nasdaq cites voluntary withdrawal compliance for Sangamo Therapeutics (SGMOQ) common stock. Stock Titan Sangamo Therapeutics: Nasdaq gives delisting notice Sangamo Therapeutics, Inc.'s common stock is the subject of a Nasdaq Stock Market…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
manilatimes.net1
-
stocktitan.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.